Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia

Table 1 Clinical characteristics of patients with ITP

Patient	Gender	Age	Platelets (×10⁹/L)	Bleeding symptoms	Major therapy	Platelets (×10⁹/L)
Patient	Gender	Age	Before treatment	Bleeding symptoms	Major therapy	After treatment
1	F	54	23	EC	GC	118
2	F	37	6	EC, PT	GC	154
3	F	23	15	EC, EP	GC	98
4	F	58	18	EP, GUH	GC	222
5	F	48	3	EC, GUH	GC	245
6	M	67	12	PT	GC	97
7	F	40	10	PT	GC	56
8	M	59	4	EC	GC	234
9	F	60	27	EC, GUH	GC	67
10	M	70	10	EC, PT	GC	21
11	M	49	9	PT	GC	180
12	M	12	34	EC	GC	78
13	F	13	21	EC	GC	203
14	F	26	10	EC, GIH	GC	82
15	F	28	19	EC	GC	168
16	M	65	20	EC, GIH	GC	166
17	M	42	11	PT	GC	267
18	F	17	9	EC	GC	80
19	F	56	2	PT	GC	9
20	M	61	27	PT	GC	174
21	F	63	10	EC, GH	GC	199
22	F	50	14	EC, PT	GC	143
23	M	31	11	EC	GC	20
24	F	26	25	PT	GC	156
25	F	71	21	PT	GC	151
26	F	51	28	EC, GUH	GC	32
27	F	28	8	PE, PT, ET	GC	103
28	F	24	9	EC, EP	GC	197
29	F	29	16	PT	GC	173
30	F	34	22	PT	GC	129
31	F	41	7	PE, PT	GC	301
32	F	20	5	EC, GUH	GC	24
33	M	25	23	PT	GC	71
34	M	37	3	PT	GC	96
35	F	19	2	EC, PT	GC	136
36	M	33	7	PT	GC	84
37	F	46	16	PT	GC	183
38	F	42	10	PT	GC	158
Median		40.5	10			148.5
Range		12–71	2–34			9–301

EC ecchymoses; GC glucocorticoid; PT petechiae; EP epistaxis; GUH genitourinary hemorrhage; GIH gastrointestinal hemorrhage; GH gingival hemorrhage

ISSN: 1479-5876